Effects of thalidomide therapy in symptomatic simian immunodeficiency virus-infected cynomolgus monkeys.
Di Fabio
S
S
Trabattoni
D
D
Geraci
A
A
Ruzzante
S
S
Panzini
G
G
Fusi
M L
ML
Chiarotti
F
F
Corrias
F
F
Belli
R
R
Verani
P
P
Dalgleish
A
A
Clerici
M
M
Titti
F
F
D000284:Administration, Oral; D000818:Animals; D018106:CD28 Antigens / Q000276:immunology; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008252:Macaca fascicularis; D016097:Simian Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D015302:Simian Immunodeficiency Virus / Q000302:isolation & purification*; D013792:Thalidomide / Q000008:administration & dosage*; D019562:Viral Load
D018106:CD28 Antigens; D007166:Immunosuppressive Agents; D013792:Thalidomide